Akso Health Group (AHG) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2023
Loading P/E history...
AHG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Akso Health Group (AHG) trades at a price-to-earnings ratio of -4.3x, with a stock price of $2.05 and trailing twelve-month earnings per share of $-0.40.
The current P/E is 160% below its 5-year average of 7.1x. Over the past five years, AHG's P/E has ranged from a low of 0.0x to a high of 58.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.1x, AHG trades at a 132% discount to its sector peers. The sector includes 775 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, AHG trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AHG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AHG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $534M | 1.7Lowest | 0.12 | -18% | |
| $4B | 2.1 | 0.11Best | +61% | |
| $147M | 2.2 | - | +3% | |
| $3B | 3.8 | 1.13 | +8% | |
| $2B | 60.5 | - | -63% | |
| $589M | 9.2 | - | +225%Best | |
| $4B | 43.2 | 1.22 | -10% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AHG Historical P/E Data (2018–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Sat Dec 31 2022 00:00:00 GM | $0.38 | $1.48 | 0.3x | -96% |
| FY2023 Q2 | Fri Sep 30 2022 00:00:00 GM | $0.91 | $1.78 | 0.5x | -93% |
| FY2023 Q1 | $1.02 | $4.67 | 0.2x | -97% | |
| FY2022 Q4 | $1.69 | $3.78 | 0.4x | -94% | |
| FY2021 Q3 | $2.47 | $12375.96 | 0.0x | -100% | |
| FY2021 Q2 | Wed Sep 30 2020 00:00:00 GM | $1.48 | $12372.93 | 0.0x | -100% |
| FY2021 Q1 | $2.42 | $12368.01 | 0.0x | -100% | |
| FY2020 Q4 | $3.78 | $12368.31 | 0.0x | -100% | |
| FY2019 Q4 | Sun Mar 31 2019 00:00:00 GM | $30.06 | $0.51 | 58.9x | +726% |
| FY2019 Q3 | Mon Dec 31 2018 00:00:00 GM | $22.50 | $2.94 | 7.7x | +7% |
| FY2019 Q2 | Sun Sep 30 2018 00:00:00 GM | $70.92 | $9.39 | 7.6x | +6% |
| FY2019 Q1 | Sat Jun 30 2018 00:00:00 GM | $90.54 | $15.27 | 5.9x | -17% |
Average P/E for displayed period: 7.1x
See AHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHG vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonAHG — Frequently Asked Questions
Quick answers to the most common questions about buying AHG stock.
Is AHG stock overvalued or undervalued?
AHG trades at -4.3x P/E, below its 5-year average of 7.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AHG's valuation compare to peers?
Akso Health Group P/E of -4.3x compares to sector median of 13.1x. The discount suggests lower growth expectations or higher risk.
What is AHG's PEG ratio?
AHG PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2023.